Company Filing History:
1 out of 820 
1 out of 4 
1 out of 6 Years Active: 2002-2014
Title: Takuji Shirasawa: Innovator in Therapeutic Antibodies and Protein Kinases
Introduction
Takuji Shirasawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of biotechnology and medicine, particularly in the development of therapeutic methods targeting amyloid beta proteins. With a total of 2 patents, his work has the potential to impact the treatment of neurodegenerative diseases such as Alzheimer's.
Latest Patents
One of Shirasawa's latest patents involves an antibody that recognizes a specific turn structure in amyloid beta (Aβ). This invention provides a therapeutic method that exclusively targets the Aβ protein, particularly focusing on the turn structure at amino acid positions 22 and 23. Additionally, this patent includes a medicinal composition that comprises an antibody specifically recognizing a toxic conformer of amyloid beta, along with an assay kit for detecting this toxic conformer and a diagnostic tool for Alzheimer's disease.
Another notable patent pertains to a serine/threonine protein kinase. In this work, a mouse cDNA encoding a protein with a serine/threonine protein kinase region was isolated using PCR techniques. The research involved screening a mouse cDNA library and successfully isolating multiple human and mouse cDNAs with similar structures. Furthermore, an antisense DNA against the isolated mouse cDNA was synthesized, and its effects on nerve cells were studied, confirming that it inhibits axonal elongation.
Career Highlights
Shirasawa has worked with esteemed institutions such as Kyoto University and the Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology. His research has been pivotal in advancing our understanding of protein interactions and their implications in neurodegenerative diseases.
Collaborations
Throughout his career, Takuji Shirasawa has collaborated with notable colleagues, including Kazuhiro Irie and Kazuma Murakami. These partnerships have contributed to the success of his research endeavors and the development of innovative therapeutic solutions.
Conclusion
Takuji Shirasawa's contributions to the fields of biotechnology and medicine are noteworthy. His innovative patents and research efforts continue to pave the way for advancements in the treatment of Alzheimer's disease and other neurodegenerative conditions.